Free Trial

Neuphoria Therapeutics Inc. - Common Stock (NEUP) Earnings Date, Estimates & Call Transcripts

Neuphoria Therapeutics Inc. - Common Stock logo
$5.72 -0.08 (-1.38%)
As of 03/28/2025 04:00 PM Eastern

Neuphoria Therapeutics Inc. - Common Stock Latest Earnings Summary

Latest Q2 2025
Earnings Date
Feb. 14Estimated
Actual EPS
(Feb. 14)
-$1.23 Beat By $0.78
Consensus EPS
(Feb. 14)
-$2.01

Neuphoria Therapeutics Inc. - Common Stock released Q2 2025 earnings on February 14, 2025, reporting an EPS of -$1.23, which beat the consensus estimate of -$2.01 by $0.78. Quarterly revenue was reported to be $660 billion. With a trailing EPS of $0.00, Neuphoria Therapeutics Inc. - Common Stock's earnings are expected to decrease next year, from ($1.56) to ($1.85) per share.

Get Neuphoria Therapeutics Inc. - Common Stock Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Neuphoria Therapeutics Inc. - Common Stock and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

NEUP Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

NEUP Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.
Remove Ads

Neuphoria Therapeutics Inc. - Common Stock Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20251-$2.01-$2.01-$2.01
Q3 20251-$0.47-$0.47-$0.47
Q4 20251-$1.26-$1.26-$1.26
20253-$3.74-$3.74-$3.74
Q1 20261-$0.55-$0.55-$0.55
Q2 20261-$0.61-$0.61-$0.61
Q3 20261-$0.42-$0.42-$0.42
Q4 20261-$0.42-$0.42-$0.42
FY 20264($2.00)($2.00)($2.00)
Remove Ads

Neuphoria Therapeutics Inc. - Common Stock Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
2/14/2025Q2 2025-$2.01-$1.23+$0.78-$1.23-$660.00B

Neuphoria Therapeutics Inc. - Common Stock Earnings - Frequently Asked Questions

Neuphoria Therapeutics Inc. - Common Stock (NASDAQ:NEUP) last announced its quarterly earning data on Friday, February 14, 2025. Learn more on NEUP's earnings history.

In the previous quarter, Neuphoria Therapeutics Inc. - Common Stock (NASDAQ:NEUP) reported ($1.23) earnings per share (EPS) to beat the analysts' consensus estimate of ($2.01) by $0.78. Learn more on analysts' earnings estimate vs. NEUP's actual earnings.

Neuphoria Therapeutics Inc. - Common Stock (NASDAQ:NEUP) has a recorded annual revenue of $662,715.00.

Neuphoria Therapeutics Inc. - Common Stock (NASDAQ:NEUP) has a recorded net income of -$15.49 million. NEUP has generated $0.00 earnings per share over the last four quarters.

Neuphoria Therapeutics Inc. - Common Stock's earnings are expected to decrease from ($1.56) per share to ($1.85) per share in the next year.

More Earnings Resources from MarketBeat

Remove Ads


This page (NASDAQ:NEUP) was last updated on 3/29/2025 by MarketBeat.com Staff
From Our Partners